The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,093.00
Bid: 1,093.00
Ask: 1,099.00
Change: 2.00 (0.18%)
Spread: 6.00 (0.549%)
Open: 1,080.00
High: 1,098.00
Low: 1,073.00
Prev. Close: 1,091.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

26 Jul 2016 07:00

RNS Number : 1804F
Fevertree Drinks PLC
26 July 2016
 

26th July 2016

 

Fevertree Drinks plc ("Fever-Tree")

 

Interim Results

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces its Interim Results for the period ended 30 June 2016.

 

Financial Highlights:

 

· Revenue up 69% to £40.6m (H1 2015: £24.1m)

· Gross margin of 54.8% (H1 2015: 50.5%)

· Adjusted EBITDA1 up 72% to £12.4m (H1 2015: £7.2m)

· Strong balance sheet with net cash at period end of £18.6m (H1 2015: £7.9m)

· Diluted EPS up 83% to 8.12 pence (H1 2015: 4.44 pence)

· Interim dividend up 97% to 1.54 pence per share (H1 2015: 0.78 pence)

 

Operational Highlights:

 

· Strong growth across all regions

· Particularly notable performance within UK Off-Trade complemented by the addition of new distribution in the period

· Successful UK roll-out of the 150ml premium can format including listing of Naturally Light Tonic Water cans with easyJet

· New importers appointed in Spain and Netherlands to position Group for next stage of growth in those territories

· Launch of new bespoke embossed bottles in June 2016, to be rolled out internationally over H2

 

Post-period Highlight:

 

· Expanded current distribution of tonic water with British Airways across the entire fleet

 

Tim Warrillow, CEO of Fever-Tree said:

 

"We are delighted to report that the Group's strong performance throughout 2015 has continued into the first half of 2016. Growth has continued to come from all of our regions as evidenced by further distribution gains in both the On and Off-Trade, as well as continued underlying sales growth.

 

"We have made excellent progress in developing the optimum infrastructure, relationships and team to capitalise on the strength of our brand and market leading position as the trend for premium spirits continues to gather momentum across all our key geographies."

 

1Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, share based payment charges and finance costs

 

 

Fever-Tree will be hosting a pop-up G&T bar located in the heart of the City at Broadgate's Finsbury Avenue Square by Liverpool Street Station on Tuesday 26th July between 12.00 and 22.30. There will be a range of G&Ts to choose from, with Fever-Tree's portfolio of all natural mixers and tonics expertly paired with premium spirits.

 

For further information:

 

Fevertree Drinks plc

c/o FTI +44 (0)20 3727 1000

Tim Warrillow, Co-founder and CEO

 

Charles Rolls, Co-founder and Executive Deputy Chairman

 

Andy Branchflower, Finance Director

 

 

 

FTI Consulting - Financial PR

+44 (0)20 3727 1000

Jonathon Brill

fever-tree@fticonsulting.com

Oliver Winters

 

Georgina Goodhew

 

Tom Hufton

 

 

 

Investec Bank plc - Nominated Adviser and Broker

+44 (0)20 7597 4000

Garry Levin

 

Alex Wright

 

Matt Lewis

 

David Anderson

 

 

 

 

Updated Imagery:

 

Updated Company imagery can be accessed here - http://www.fever-tree.com/corporate/image-library

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 50 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On-Trade") as well as selected retail outlets ("Off-Trade"). Approximately 65 per cent of the Group's sales were derived from outside of the UK in financial year 2015, with key overseas markets in the US and Europe.

 

 

Chief Executive's report

I am delighted to report that the Group's strong performance in 2015 has continued in the first half of 2016. During the period we achieved revenue of £40.6m, representing growth of 69% on the first half of 2015.

 

Our gross profit margin has improved to 54.8% (H1 2015: 50.5%) and the Group achieved an adjusted EBITDA of £12.4m in the first half of the year (H1 2015: £7.2m), generating diluted earnings per share of 8.12p (H1 2015: 4.44p). We begin the second half of 2016 with a strong balance sheet and net cash of £18.6m (H1 2015: £7.9m).

 

Results

 

 

Half year ended 30 June 2016

Half year ended 30 June 2015

Movement

 

£m

£m

%

 

 

 

 

Revenue

40.6

24.1

69%

 

 

 

 

Gross Profit

22.3

12.1

83%

Gross Profit margin

54.8%

50.5%

 

 

 

 

 

Adjusted EBITDA

12.4

7.2

72%

Adjusted EBITDA margin

 

30.7%

30.0%

 

 

 

 

 

Diluted EPS

8.12

4.44

83%

Interim Dividend

1.54p

0.78p

97%

 

 

 

 

 

Territory review

Revenue by territory

 

Half year ended 30 June 2016

Half year ended 30 June 2015

Movement

Share of revenue

 

£m

£m

%

%

 

 

 

 

 

UK

15.8

7.6

108%

39%

Continental Europe

13.4

9.4

42%

33%

USA

9.2

5.8

59%

23%

RoW

2.2

1.3

73%

5%

 

 

 

 

 

Total

40.6

24.1

69%

100%

 

 

 

 

 

 

UK

The UK remains the Group's largest market, increasing to 39% of Group sales with revenue growth of 108% compared to the first half of 2015.

 

Sales growth remains strong in the On-Trade, where 57% of UK revenue is achieved. This performance was driven by our increasing distribution footprint, combined with underlying rate of sale growth as the premium gin and tonic movement continues to gather momentum across the UK. We have expanded our UK sales team to enable the Group to work more closely with key wholesale partners and focus on a wider geographical area, enabling us to continue to drive our first mover advantage within the market.

 

Growth was exceptional in the Off-Trade in the first half of 2016. This was helped by momentum from the significant distribution gains made in the second half of 2015, particularly following the launch of the 150ml cans, and complemented by the addition of new distribution in the period, including a listing with Asda. This has combined with continued rate of sale growth to drive the exceptional performance, albeit stronger comparators will be lapped in the second half of 2016.

 

The success of the 150ml can format since launch in June 2015 is particularly notable, representing 24% of sales in the Off-Trade channel in the first half of 2016. The range has also been extended to include an Elderflower Tonic flavour. Within the travel sector, a successful listing for the Naturally Light 150ml can on easyJet was followed post period end with an expansion of the current distribution of tonic water with British Airways across the entire fleet.

 

Fever-Tree now represents an 11% value share within the UK retail mixer category, approaching the 16.5% proposed as the target value share benchmark by EY for the entire premium segment in their 2014 study. Whilst it would now appear that this 16.5% value share target is conservative given the continued rise in the premiumisation of spirits, it is also reasonable to expect the exceptional growth rate in UK Off-Trade achieved over the last 18 months to remain strong but to naturally settle to lower levels.

 

Continental Europe

 

Revenue growth of 42% was achieved in the period, which represented growth of 33% when adjusted for the strengthening Euro. This result was achieved against tough comparatives, annualising 2015 retail distribution gains and a notable month of sales in June 2015 when certain importers took particularly large orders in advance of the summer season. The Group has appointed new importers in Spain and the Netherlands in the first half of 2016 which has established a strong platform for the next stage of growth in those territories. The strong underlying performance seen across Western Europe in 2015 has continued, with sales growth across all territories, the notable retail listings from 2015 performing well and a number of new retail listings achieved in the period.

 

USA

 

Revenue growth of 59% in the period represented growth of 46% when adjusted for the strengthening US dollar. Ginger Beer and Tonic flavours each represent 40% of the sales mix and are growing at 60%, reflecting the on-going opportunities with both the 'Moscow Mule' and premium gin and tonic trends. Off-Trade listings achieved in 2015 are performing well and there were further retail distribution gains and range extensions achieved in the period, meaning the Group is well placed to continue delivering good growth in the region.

 

RoW

 

Sales to countries within the RoW region have grown by 73%, with Australia and Canada seeing strong On-Trade growth and successful initial Off-Trade listings with major local retailers. The growth in revenue came from our existing geographic footprint where we believe there remains significant potential over the medium and longer term. In addition, we are actively reviewing new territories but no appointments were made in the first half of the period.

 

 

Financial and Operational

Gross margin and operating expenses

 

Gross margin of 54.8% in the period represents an increase from the 50.5% achieved in the first half of 2015. This improvement has been driven by product cost and logistics efficiencies which were achieved in the second half of 2015 and have been retained in 2016. Alongside these underlying efficiencies has been the positive impact of forex movements across the period, with an already stronger Euro and Dollar over the period further strengthening in late June 2016.

 

Underlying operating expenses1 increased as a proportion of revenue to 24.2% during the period (H1 2015: 20.4%), however, the EBITDA margin still improved to 30.7% (H1 2015: 30.0%). For the current period underlying operating expenses include an incremental £1.4m unrealised loss made on outstanding forward exchange contracts at June 2016, following the rapid strengthening of Euro and Dollar at the end of that month. Disregarding foreign exchange-related movements, the level of other underlying operating expenses is comparable to the prior period at 21.5% of revenue (H1 2015: 21.5%).

 

Cash position and working capital

 

The Group had net cash of £18.6m at period end, with £24.7m of cash at the bank offset by £6.1m of bank loans. Adjusted operating cash flow in the period was strong at 95% of adjusted EBITDA, albeit this conversion rate is influenced by seasonality and is expected to return to levels seen historically as we progress through the remainder of the year.

 

Operational

In June 2016 the Group introduced a new bespoke embossed bottle in the UK which will be rolled out internationally over the second half of the year. Alongside this, the Group has launched a new Aromatic Tonic Water in the UK and extended the 150ml can range to include Elderflower Tonic Water. Post period end we have launched a new Clementine Tonic Water in Belgium, which was developed in collaboration with the chef Sergio Herman.

 

The Group's primary bottling partner in the UK has finalised investment in a new site, which will double their existing capacity from 2017 onwards and further improves production contingency for the Group. The Group now bottles and cans with four partners across the UK and Europe and as per our stated strategy, in the first half of 2016 we have been actively exploring further opportunities to bottle closer to our main sales regions.

 

Dividend

Reflecting the Board's continued confidence in the outlook, the Directors are pleased to declare an interim dividend of 1.54 pence per share. The dividend will be paid on 9 September 2016, to shareholders on the register on 12 August 2016.

 

Outlook

 

We are encouraged by our performance in the first half of the year and the Board remains positive about the outlook for 2016.

 

 

Tim Warrillow

Chief Executive

 

 

1 Underlying operating expenses are defined as administrative expenses less depreciation, amortisation and share based payment charges

 

 

Consolidated statement of comprehensive income

For the six months ended 30 June 2016

 

 

 

Six months ended

Six months ended

Year ended

 

30 June

30 June

31 December

 

 

2016

2015

2015

 

Note

£

£

£

 

 

 

 

 

Revenue

2

40,582,364

24,069,646

59,252,617

 

 

 

 

 

Cost of sales

 

(18,328,176)

(11,921,618)

(28,377,765)

 

 

 

 

 

 

 

 

 

 

Gross profit

 

22,254,188

12,148,028

30,874,852

 

 

 

 

 

Administrative expenses

 

(10,383,071)

(5,366,114)

(13,606,120)

 

 

 

 

 

Adjusted EBITDA*

 

12,441,007

7,229,525

18,182,469

Depreciation

 

(105,288)

(54,985)

(123,924)

Amortisation

 

(360,000)

(360,000)

(720,000)

Share based payment charges

 

(104,602)

(32,626)

(69,813)

 

 

 

 

 

Operating profit

 

11,871,117

6,781,914

17,268,732

 

 

 

 

 

Finance costs

 

 

 

 

Finance income

 

37,299

5,023

27,970

Finance expense

 

(111,794)

(193,767)

(536,189)

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

11,796,622

6,593,170

16,760,513

 

 

 

 

 

Tax expense

 

(2,366,492)

(1,435,758)

(3,429,730)

 

 

 

 

 

Profit for the year/period and comprehensive income attributable to equity holders of the parent company

 

9,430,130

5,157,412

13,330,783

 

 

 

 

 

 

 

 

 

 

Earnings per share for profit attributable to the owners of the parent during the year

 

 

 

 

Basic (pence)

4

8.18

4.48

11.57

Diluted (pence)

4

8.12

4.44

11.48

 

 

 

 

 

 

*Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, share based payment charges and finance costs

 

 

Consolidated statement of financial position

At 30 June 2016

 

 

 

30 June

30 June

31 December

 

 

2016

2015

2015

 

 

£

£

£

Non-current assets

 

 

 

 

Property, plant and equipment

 

770,496

411,164

589,410

Intangible assets

 

43,490,655

44,210,655

43,850,655

Total non-current assets

 

44,261,151

44,621,819

44,440,065

 

 

 

 

 

Current assets

 

 

 

 

Inventories

 

5,905,188

5,391,968

6,376,673

Trade and other receivables

 

20,424,129

10,764,817

16,796,154

Derivative financial instruments

 

260,240

458,054

-

Cash and cash equivalents

 

24,705,172

13,975,803

17,641,024

Total current assets

 

51,294,729

30,590,642

40,813,851

 

 

 

 

 

Total assets

 

95,555,880

75,212,461

85,253,916

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

10,674,805

6,983,416

9,256,511

Derivative financial instruments

 

1,680,564

-

267,718

Loans and borrowings

 

-

634,784

936,086

Corporation tax liability

 

2,284,925

1,413,894

1,642,096

Total current liabilities

 

14,640,294

9,032,094

12,102,411

 

 

 

 

 

Non-current liabilities

 

 

 

 

Loans and borrowings

 

6,089,369

5,461,339

5,137,500

Deferred tax liability

 

2,518,959

2,607,661

2,590,959

Total non-current liabilities

 

8,608,328

8,069,000

7,728,459

 

 

 

 

 

Total liabilities

 

23,248,622

17,101,094

19,830,870

 

 

 

 

 

Net assets

 

72,307,258

58,111,367

65,423,046

 

 

 

 

 

Equity attributable to equity holders of the company

 

 

 

 

Share capital

 

288,102

288,102

288,102

Share premium

 

53,521,386

53,521,386

53,521,386

Capital Redemption Reserve

 

93,189

93,189

93,189

Retained earnings

 

18,404,581

4,208,690

11,520,369

 

 

 

 

 

Total equity

 

72,307,258

58,111,367

65,423,046

 

Consolidated statement of cash flows

For the six months ended 30 June 2016

 

 

Period ended

Period ended

Year ended

30 June

30 June

31 December

 

2016

2015

2015

 

£

£

£

Operating activities

 

 

 

Profit before tax

11,796,622

6,593,170

16,760,513

Finance expense

111,794

193,767

536,189

Finance income

(37,299)

(5,023)

(27,970)

Depreciation of property, plant and equipment

105,288

54,985

123,925

Amortisation of intangible assets

360,000

360,000

720,000

Share based payments

104,602

32,626

69,813

 

12,441,007

7,229,525

18,182,470

 

 

 

 

(Increase)/Decrease in trade and other receivables

(3,888,215)

(2,829,534)

(8,405,952)

(Increase)/Decrease in inventories

471,485

(1,045,800)

(2,030,505)

Increase/(Decrease) in trade and other payables

2,831,140

2,595,918

5,143,693

 

(585,590)

(1,279,416)

(5,292,764)

 

 

 

 

Cash generated from operations

11,855,417

5,950,109

12,889,706

 

 

 

 

Income taxes paid

(1,787,986)

(752,469)

(2,534,707)

 

 

 

 

Net cash flows from operating activities

10,067,431

5,197,640

10,354,999

 

 

 

 

Investing activities

 

 

 

Purchase of property, plant and equipment

(286,372)

(114,450)

(361,635)

 

 

 

 

Net cash used in investing activities

(286,372)

(114,450)

(361,635)

 

 

 

 

Financing activities

 

 

 

Interest (paid)

(103,669)

(152,893)

(294,021)

Interest received

37,299

7,916

27,970

Loans repaid

-

(200,000)

(425,000)

Dividends paid

(2,650,541)

(345,723)

(1,244,602)

 

 

 

 

Net cash used in financing activities

(2,716,911)

(690,700)

(1,935,653)

 

 

 

 

Net increase in cash and cash equivalents

7,064,148

4,392,490

8,057,711

 

 

 

 

Cash and cash equivalents at beginning of period

17,641,024

9,583,313

9,583,313

 

 

 

 

Cash and cash equivalents at end of period

24,705,172

13,975,803

17,641,024

 

 

 

 

 

 

 

 

 

 

Notes to the consolidated financial statements

For the six months ended 30 June 2016

 

1. Basis for preparation

The interim financial statements have been prepared in accordance with the recognition and measurement requirements of International Financial Reporting Standards (IFRS) and IFRIC interpretations issued by the International Accounting Standards Board (IASB) adopted by the European Union.

The accounts have been prepared in accordance with accounting policies that are consistent with the December 2015 Report and Accounts and that are expected to be applied in the Report and Accounts of the year ended 31 December 2015. There are new or revised standards or interpretations that apply to the period beginning 1 January 2016 but they do not have a material effect on the financial statements for the period ended 30 June 2016.

This report is not prepared in accordance with IAS 34, which is not mandatory. The financial information does not constitute statutory accounts within the meaning of section 435 of the Companies Act 2006. Statutory accounts for Fevertree Drinks Plc for the year ended 31 December 2015 have been delivered to the Registrar of Companies. The auditors' report on those accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006.

2. Revenue

An analysis of turnover by geographical market is given below:

 

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

 

2016

2015

2015

 

£

£

£

 

 

 

 

United Kingdom

15,797,208

7,590,177

20,460,667

Continental Europe

13,367,379

9,408,768

22,360,850

United States of America

9,237,070

5,809,368

13,690,012

Rest of the World

2,180,707

1,261,333

2,741,088

 

40,582,364

24,069,646

59,252,617

 

3. Dividends

The interim dividend of 1.54p will be paid on 9 September 2016 to shareholders on the register on 12 August 2016.

 

4. Earnings Per Share

 

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

 

2016

2015

2015

 

£

£

£

Profit

 

 

 

Profit used in calculating basic and diluted EPS

9,430,130

5,157,412

13,330,783

 

 

 

 

Number of shares

 

 

 

Weighted average number of shares for the purpose of

basic earnings per share

115,240,896

115,240,896

115,240,896

Weighted average number of employee share options outstanding

938,112

842,531

853,692

Weighted average number of shares for the purpose of

diluted earnings per share

116,179,008

116,083,427

116,094,588

 

 

 

 

Basic earnings per share (pence)

8.18

4.48

11.57

 

 

 

 

Diluted earnings per share (pence)

8.12

4.44

11.48

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DELFLQDFFBBF
Date   Source Headline
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM
25th May 20237:00 amRNSBoard Changes
25th May 20237:00 amRNSAGM Trading Statement
12th May 202311:25 amRNSHolding(s) in Company
5th May 20237:00 amRNSGrant of Options
2nd May 20237:00 amRNSTotal Voting Rights
21st Apr 20231:08 pmRNSNotice of AGM
22nd Mar 20237:00 amRNSFY22 Preliminary Results to 31 December 2022
8th Mar 20239:49 amRNSHolding(s) in Company
8th Feb 20232:56 pmRNSStandard form for notification of major holdings
30th Jan 20234:32 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSFY22 pre-close trading update
17th Jan 20239:45 amRNSStandard form for notification of major holdings
19th Dec 20227:00 amRNSBlock Admission Application
12th Dec 20227:00 amRNSDomenic De Lorenzo to succeed Bill Ronald as Chair
1st Dec 20229:00 amRNSBlock Listing Return
21st Nov 20227:00 amRNSChange Of Nominated Advisor and Corporate Broker
15th Nov 20226:18 pmRNSStandard form for notification of major holdings
1st Nov 20227:00 amRNSTotal Voting Rights
17th Oct 20223:09 pmRNSStandard form for notification of major holdings
4th Oct 202210:25 amRNSDirector/PDMR Shareholding
3rd Oct 20229:00 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSFever-Tree FY22 Interim Results
1st Sep 20227:00 amRNSTotal Voting Rights
24th Aug 202212:06 pmRNSStandard form for notification of major holdings
19th Jul 20229:57 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20224:00 pmRNSDirector/PDMR Shareholding
15th Jul 202210:14 amRNSDirector/PDMR Shareholding
15th Jul 20227:00 amRNSHY pre-close trading update
1st Jul 20222:26 pmRNSFever Tree drinks plc Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.